The Pathways between Cortisol-Related Regulation Genes and PTSD Psychotherapy.
Ontology highlight
ABSTRACT: Post-traumatic stress disorder (PTSD) only develops after exposure to a traumatic event in some individuals. PTSD can be chronic and debilitating, and is associated with co-morbidities such as depression, substance use, and cardiometabolic disorders. One of the most important pathophysiological mechanisms underlying the development of PTSD and its subsequent maintenance is a dysfunctional hypothalamic-pituitary-adrenal (HPA) axis. The corticotrophin-releasing hormone, cortisol, glucocorticoid receptor (GR), and their respective genes are some of the mediators of PTSD's pathophysiology. Several treatments are available, including medication and psychotherapies, although their success rate is limited. Some pharmacological therapies based on the HPA axis are currently being tested in clinical
SUBMITTER: Castro-Vale I
PROVIDER: S-EPMC7712185 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA